Omega Therapeutics Inc (OMGA)
Omega Therapeutics Market Cap: 116.38M for May 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 28, 2024 | 116.38M |
May 24, 2024 | 117.48M |
May 23, 2024 | 116.93M |
May 22, 2024 | 123.00M |
May 21, 2024 | 120.79M |
May 20, 2024 | 136.23M |
May 17, 2024 | 132.92M |
May 16, 2024 | 131.27M |
May 15, 2024 | 125.75M |
May 14, 2024 | 130.17M |
May 13, 2024 | 129.89M |
May 10, 2024 | 108.10M |
May 09, 2024 | 119.69M |
May 08, 2024 | 118.31M |
May 07, 2024 | 118.86M |
May 06, 2024 | 125.75M |
May 03, 2024 | 142.30M |
May 02, 2024 | 152.23M |
May 01, 2024 | 136.78M |
April 30, 2024 | 123.00M |
April 29, 2024 | 126.30M |
April 26, 2024 | 125.20M |
April 25, 2024 | 129.61M |
April 24, 2024 | 128.51M |
April 23, 2024 | 129.06M |
Date | Value |
---|---|
April 22, 2024 | 131.82M |
April 19, 2024 | 132.37M |
April 18, 2024 | 133.48M |
April 17, 2024 | 140.92M |
April 16, 2024 | 132.92M |
April 15, 2024 | 138.71M |
April 12, 2024 | 147.54M |
April 11, 2024 | 163.26M |
April 10, 2024 | 166.02M |
April 09, 2024 | 166.57M |
April 08, 2024 | 170.43M |
April 05, 2024 | 162.71M |
April 04, 2024 | 166.57M |
April 03, 2024 | 159.12M |
April 02, 2024 | 166.02M |
April 01, 2024 | 176.50M |
March 28, 2024 | 201.32M |
March 27, 2024 | 195.80M |
March 26, 2024 | 186.98M |
March 25, 2024 | 188.08M |
March 22, 2024 | 187.53M |
March 21, 2024 | 196.90M |
March 20, 2024 | 192.46M |
March 19, 2024 | 189.15M |
March 18, 2024 | 194.11M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Fate Therapeutics Inc | 402.97M |
Macrogenics Inc | 271.83M |
Ocular Therapeutix Inc | 918.49M |
AnaptysBio Inc | 636.25M |
Verrica Pharmaceuticals Inc | 358.03M |
Market Cap Related Metrics
PS Ratio | 23.55 |
Price to Book Value | 2.814 |
Price | 2.11 |
Earnings Yield | -78.67% |